BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 17503896)

  • 1. Oral anticancer drugs in the elderly: an overview.
    Lonardi S; Bortolami A; Stefani M; Monfardini S
    Drugs Aging; 2007; 24(5):395-410. PubMed ID: 17503896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology of anticancer drugs in the elderly population.
    Wildiers H; Highley MS; de Bruijn EA; van Oosterom AT
    Clin Pharmacokinet; 2003; 42(14):1213-42. PubMed ID: 14606930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of the changing paradigm in cancer treatment: oral chemotherapy.
    Aisner J
    Am J Health Syst Pharm; 2007 May; 64(9 Suppl 5):S4-7. PubMed ID: 17468157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic considerations of oral chemotherapy in elderly patients with cancer.
    Skirvin JA; Lichtman SM
    Drugs Aging; 2002; 19(1):25-42. PubMed ID: 11929325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology of antineoplastic agents in older cancer patients.
    Lichtman SM; Skirvin JA; Vemulapalli S
    Crit Rev Oncol Hematol; 2003 May; 46(2):101-14. PubMed ID: 12711355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NCCN Task Force Report: Oral chemotherapy.
    Weingart SN; Brown E; Bach PB; Eng K; Johnson SA; Kuzel TM; Langbaum TS; Leedy RD; Muller RJ; Newcomer LN; O'Brien S; Reinke D; Rubino M; Saltz L; Walters RS
    J Natl Compr Canc Netw; 2008 Mar; 6 Suppl 3():S1-14. PubMed ID: 18377852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The handling of anti-cancer drugs in elderly patients].
    Gaujard S; Albrand G; Bonnefoy M; Courpron P; Freyer G
    Presse Med; 2005 May; 34(9):673-80. PubMed ID: 15988347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacology issues relevant to the dosing and toxicity of chemotherapy drugs in the elderly.
    Wasil T; Lichtman SM
    Oncologist; 2005 Sep; 10(8):602-12. PubMed ID: 16177284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of antineoplastic agents in older cancer patients.
    Lichtman SM; Skirvin JA
    Oncology (Williston Park); 2000 Dec; 14(12):1743-55; discussion 1755, passim. PubMed ID: 11204376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacology of anticancer drugs in the elderly: tools for dose-adjustment].
    Tranchand B; Falandry C; You B; Girard P; Ribba B; Tod M; Freyer G
    Bull Cancer; 2008 May; 95 FMC Onco():F21-7. PubMed ID: 18511363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cancer chemotherapy in patients older than 75 years old--from the aspect of clinical pharmacology].
    Tanaka K; Okumura K
    Gan To Kagaku Ryoho; 1998 Jun; 25(7):995-9. PubMed ID: 9644313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacoeconomic and clinical outcomes in oncology using oral chemotherapy.
    Navarro RP; Morrow T; Baran R
    Manag Care Interface; 2002 Jul; 15(7):55-62. PubMed ID: 12143298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy in the elderly: pharmacologic considerations.
    Lichtman SM; Villani G
    Cancer Control; 2000; 7(6):548-56. PubMed ID: 11088063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence, compliance and persistence to oral antineoplastic therapy: a review focused on chemotherapeutic and biologic agents.
    Gebbia V; Bellavia G; Ferraù F; Valerio MR
    Expert Opin Drug Saf; 2012 May; 11 Suppl 1():S49-59. PubMed ID: 22149481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticancer oral therapy: emerging related issues.
    Banna GL; Collovà E; Gebbia V; Lipari H; Giuffrida P; Cavallaro S; Condorelli R; Buscarino C; Tralongo P; Ferraù F
    Cancer Treat Rev; 2010 Dec; 36(8):595-605. PubMed ID: 20570443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physicians' preferences for prescribing oral and intravenous anticancer drugs: a Discrete Choice Experiment.
    Benjamin L; Cotté FE; Philippe C; Mercier F; Bachelot T; Vidal-Trécan G
    Eur J Cancer; 2012 Apr; 48(6):912-20. PubMed ID: 22033327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiological aspects of aging. Implications for the treatment of cancer.
    Lichtman SM
    Drugs Aging; 1995 Sep; 7(3):212-25. PubMed ID: 8535051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological factors influencing anticancer drug selection in the elderly.
    John V; Mashru S; Lichtman S
    Drugs Aging; 2003; 20(10):737-59. PubMed ID: 12875610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential role of oral anthracyclines in older patients with cancer.
    Lasota WS; de Valeriola DL; Piccart MJ
    Drugs Aging; 1994 May; 4(5):392-402. PubMed ID: 8043941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence to therapy with oral antineoplastic agents.
    Partridge AH; Avorn J; Wang PS; Winer EP
    J Natl Cancer Inst; 2002 May; 94(9):652-61. PubMed ID: 11983753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.